Here Are The Best Performing ETFs Of 2017 Thus Far

From Moby Waller: A huge amount of money goes into passive stock market tracking these days, through the S&P 500 Index (SPY) and other major U.S. indexes (DIA) (QQQ) (IWM). This strategy has done well in general in recent years and has gained popularity, particularly in retirement-type accounts.
NYSE:XBI March 17, 2017 6:21am

This New Piece Of Legislation Could Be A Huge Boon For Pharma Companies

From Sound Dollar Campaign: During the presidential campaign, the high price of prescription drugs became a blistering issue. At the same time, the Mylan/EpiPen scandal broke.
NYSE:XBI January 6, 2017 6:33am

Biotech Stocks Plunge As Trump Vows To Lower Drug Prices

The iShares NASDAQ Biotechnology Index ETF (NASDAQ:IBB) was on the decline this morning, after Donald Trump's TIME Person of the Year profile revealed that the president-elect likely won't be the bullish force for drug companies many thought he'd be.
NASDAQ:IBB December 7, 2016 9:18am

Biotech ETFs Have Room to Run, with Several Catalysts Ahead

Biotech pillsThe iShares NASDAQ Biotechnology Index ETF (NASDAQ:IBB) has recovered nicely from its yearly lows, and there's reason to believe that more gains are on the horizon as well.
NASDAQ:IBB September 30, 2016 10:22am

This Biotech ETF is Breaking Out to the Upside

From Gary Savage: Today's chart of the day focuses on a well-known biotech ETF, the SPDR S&P Biotech ETF (NYSE:XBI), which is threatening to break out even further to the upside.
NASDAQ:IBB September 20, 2016 9:23am

Can the Biotech Sector Turn it Around Before Year-End?

From Zacks Research: The biotech sector has had a rough start to the year with the NASDAQ Biotechnology Index declining approximately 16% year-to-date. Sector-specific issues like increasing political and media focus on high price tags for new drugs and the changing competitive scenario have been weighing on biotech stocks over the last few quarters.
NASDAQ:IBB September 2, 2016 7:39am

Trouble Ahead For This Biotech ETF?

biotechRick Pendergraft:  The biotech sector has had a rough go of it since last July. The SPDR S&P Biotech ETF (NYSEArca: XBI) lost over half of its value from last July’s high to the February low, falling from $90.75 to $44.11.
NASDAQ:IBB April 22, 2016 2:48pm

Where Is This Big Biotech ETF Headed Now?

biotechRick Pendergraft:  The biotech sector was flying high for the first half of the year, but then the market turned in July and it is now trying to find its footing. The SPDR S&P Biotech ETF (NYSEArca: XBI) is just one of several ETFs that represent the biotech sector
NYSE:XBI December 18, 2015 4:53pm

A More Viable Way To Tap Into Pharmaceutical and Biotech Investing

biotechJJ Feldman:  Tapping into the pharmaceuticals (pharma) and biotechnology sectors can be intimidating, and picking winners in this corner of the health care market is tough.
NYSE:FBT October 13, 2015 4:19pm

Unusual ETFs With Great Potential

ETFsJJ Feldman: Creating a diversified portfolio takes time, tools, and discipline in order to implement a strategy to meet your preferred outcome.
NYSE:FPX May 27, 2015 3:02pm

The 3 Best ETFs Of Q1 2015

etfsKent Thune: In this review of the best ETFs of the first quarter of 2015, we won’t be looking to chase after short-term trends. Instead, we’ll dig beneath the surface of high returns to see what clues and insights we can find about the coming quarters.
NYSE:RZG April 6, 2015 3:25pm

ETFs To Buy On Solid Biotech Stock Earnings [Celgene Corporation, Biogen Idec Inc, Alexion Pharmaceuticals, Inc., Amgen, Inc.]

biotechBiotech stocks and the related ETFs have been the star performers this year despite some temporary glitches and rough trading in between. Encouraging industry trends, increasing merger and acquisition activities, expansion
NASDAQ:BIB October 29, 2014 5:13pm

Quick Investor Guide To Biotech ETFs [iShares NASDAQ Biotechnology Index (ETF), SPDR S&P Biotech (ETF)]

biotechMergers and acquisitions (M&As) continue to play a major role in the biotech sector and are not showing any signs of slowing down. Biotech companies have always attracted a lot of interest especially from their pharma counterparts
NASDAQ:IBB October 3, 2014 3:09pm

Big-Picture Biotech Stocks Rule The Future [Athersys, Inc., NeoStem Inc, Cempra Inc, Alcobra Ltd]

biotechWhen Steve Brozak performs diligence on biotech stocks, he's always looking for an angle. Brozak, president and managing director at WBB Securities, wants to see how new technology platforms and novel ideas fit into
NYSE:XBI September 8, 2014 11:01am

Recommended for You

Explore More from

Free Daily Newsletter

Get daily ETF insights from our market experts. Never miss another important market development again! respects your privacy.

Best ETFs

We've rated and ranked nearly 2,000 ETFs and ETNs using our proprietary SMART Grade system.

View Top Rated ETFs

Best Categories

We've ranked dozens of ETF categories based on relative performance.

Best ETF Categories